Spot diagnosis
False
General clinical
Spot diagnosis
Discuss any specialty in this open forum for all healthcare professionals
This patient received renal transplant 4 years ago, what is the most likely cause of his facial appearance ?  
0
Cat:OpenClinicalForum:GeneralClinical
Cat:OpenClinicalForum:GeneralClinicalDiscussion:02fc12f9-0730-453a-b1e0-5348249601b5
Forums » Open clinical » General clinical » Spot diagnosis
|
Re: Spot diagnosis
posted at 6/10/2012 4:42 PM BST
on bmj.com
|
|
Re: Spot diagnosis
posted at 6/10/2012 10:04 PM BST
on bmj.com
|
Posts: 268
First: 2/8/2010 Last: 19/5/2013 |
Rhinophyma is a descriptive term for a large, bulbous, ruddy appearance of the nose caused by granulomatous infiltration, and hypertrophy of the sebaceous glands of the tip of the nose commonly due to untreated rosacea Alkohol is mistakenly attributed as a cause of the disease, but heavy alkohol consumption does aggravate the condition and consequently it is more common in alkoholic patients The most recent treatment consists of paring down the bulk of the tissue with carbon dioxide laser, and allowing the area to re-epithelialise, Sometimes, the tissue is completely excised and the raw area skin-grafted Immuosuppression is one of multible causes of Rhinophyma, for other causes please refer to Wikipedia, the free encyclopedia |
|
Re: Spot diagnosis
posted at 7/10/2012 7:02 AM BST
on bmj.com
|
Posts: 3037
First: 27/3/2012 Last: 18/5/2013 |
Formerly Rhinophyma was used to describe a severe form of acne rosacea, causing the shape of the nose very big & ugly like the horn of a rhino. The given picture cannot be called rhinophyma! Please remember, even after CO2 cautery the lesions tend to recur which is not observed after treatment with dapsone, the most cost effective treatment. Other treatment modalities which are not 'curative' are intense pulse light, photodynamic therapy, or isotretinoin. You will not find reference about dapsone at wikipedia. It is the only known curative treatment mentioned in the textbooks of dermatology. |





